Tuesday, 17 November 2026 SEC EDGAR filings, as they land
ALFA USA News Straight from the SEC filing
SEC Filings

Mirum Pharmaceuticals, Inc. — Latest News

Every SEC filing by Mirum Pharmaceuticals, Inc. that we have reported, newest first. Each story links the original filing.

NASDAQ: MIRM · Biotechnology · 3 stories

Share price
$93.18
Market cap
$6.1B
Revenue (annual)
$521M

Reference market data from a third-party provider, as of the most recent story (10 Nov 2026). Not a valuation or a recommendation.

Mirum Pharmaceuticals, Inc. share price · last month
Line chart of Mirum Pharmaceuticals, Inc.'s share price over the last month, from $82.24 on 19 Oct → $91.58 on 16 Nov.

Up 11.4% over the last month ($82.24 on 19 Oct → $91.58 on 16 Nov). Daily closing prices. Source: Yahoo Finance.

Show the prices
19 Oct$82.24
20 Oct$85.07
21 Oct$83.44
22 Oct$83.10
23 Oct$80.39
26 Oct$83.27
27 Oct$85.56
28 Oct$85.81
29 Oct$86.39
30 Oct$85.00
2 Nov$85.74
3 Nov$87.03
4 Nov$96.97
5 Nov$93.54
6 Nov$93.72
9 Nov$93.18
10 Nov$94.42
11 Nov$94.61
12 Nov$93.33
13 Nov$93.99
16 Nov$91.58
Other 2Regulatory Approval 1

Track Mirum Pharmaceuticals, Inc. live

Get the next Mirum Pharmaceuticals, Inc. SEC filing seconds after it lands.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.